NCT04999332 2023-11-15
LOTS
National Cheng-Kung University Hospital
Phase 2 Unknown
Clinical Trials
12 trialsNCT01693432 2017-08-23
Docetaxel and S-1 for Advanced Esophageal Cancer
Hallym University Medical Center
Phase 2 Unknown
NCT03137004 2017-05-08
Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT02870153 2016-08-19
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
The First People's Hospital of Changzhou
Phase 2 Unknown
NCT01542294 2016-06-14
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer
ChineseAMS
Phase 1/2 Unknown
NCT01679340 2015-05-19
A Phaseâ…¡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
Peking University
Phase 2 Unknown
NCT01608646 2012-05-31
Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer
Xijing Hospital
Phase 2 Unknown
NCT00687843 2012-03-22
TMOG-GC01
Tokyo Metropolitan Oncology Group
Phase 3 Unknown
NCT01533324 2012-02-15
S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)
Second Military Medical University
Phase 2 Unknown
NCT00874328 2010-10-25
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
National Cancer Center, Korea
Phase 1/2 Unknown
NCT00961077 2009-08-18
Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer
Soonchunhyang University Hospital
Phase 2 Unknown
NCT00209651 2007-11-01
Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 2 Unknown